A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy
Hui Yang,1– 3 Shaoxing Sun,1– 3 Zijie Mei,1– 3 Qingming Xiang,1– 3 Chunxu Yang,1– 3 Min Chen,1– 3 Conghua Xie,1– 3 Yunfeng Zhou,1– 3 Hui Qiu1– 3 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 2Hubei Key Laboratory of Tumor Bio...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5f2008c894c74e8cbecb12edaf85fc3f |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|